| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.04 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.04 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.6 | 0.04 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.13 | 0.04 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.088 | 0.04 |